Cargando…

Progress of Imaging in Diabetic Retinopathy—From the Past to the Present

Advancement of imaging technology in retinal diseases provides us more precise understanding and new insights into the diseases’ pathologies. Diabetic retinopathy (DR) is one of the leading causes of sight-threatening retinal diseases worldwide. Colour fundus photography and fluorescein angiography...

Descripción completa

Detalles Bibliográficos
Autores principales: Horie, Shintaro, Ohno-Matsui, Kyoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319818/
https://www.ncbi.nlm.nih.gov/pubmed/35885588
http://dx.doi.org/10.3390/diagnostics12071684
_version_ 1784755642738671616
author Horie, Shintaro
Ohno-Matsui, Kyoko
author_facet Horie, Shintaro
Ohno-Matsui, Kyoko
author_sort Horie, Shintaro
collection PubMed
description Advancement of imaging technology in retinal diseases provides us more precise understanding and new insights into the diseases’ pathologies. Diabetic retinopathy (DR) is one of the leading causes of sight-threatening retinal diseases worldwide. Colour fundus photography and fluorescein angiography have long been golden standard methods in detecting retinal vascular pathology in this disease. One of the major advancements is macular observation given by optical coherence tomography (OCT). OCT dramatically improves the diagnostic quality in macular edema in DR. The technology of OCT is also applied to angiography (OCT angiograph: OCTA), which enables retinal vascular imaging without venous dye injection. Similar to OCTA, in terms of their low invasiveness, single blue color SLO image could be an alternative method in detecting non-perfused areas. Conventional optical photography has been gradually replaced to scanning laser ophthalmoscopy (SLO), which also make it possible to produce spectacular ultra-widefield (UWF) images. Since retinal vascular changes of DR are found in the whole retina up to periphery, it would be one of the best targets in UWF imaging. Additionally, evolvement of artificial intelligence (AI) has been applied to automated diagnosis of DR, and AI-based DR management is one of the major topics in this field. This review is trying to look back on the progress of imaging of DR comprehensively from the past to the present.
format Online
Article
Text
id pubmed-9319818
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93198182022-07-27 Progress of Imaging in Diabetic Retinopathy—From the Past to the Present Horie, Shintaro Ohno-Matsui, Kyoko Diagnostics (Basel) Review Advancement of imaging technology in retinal diseases provides us more precise understanding and new insights into the diseases’ pathologies. Diabetic retinopathy (DR) is one of the leading causes of sight-threatening retinal diseases worldwide. Colour fundus photography and fluorescein angiography have long been golden standard methods in detecting retinal vascular pathology in this disease. One of the major advancements is macular observation given by optical coherence tomography (OCT). OCT dramatically improves the diagnostic quality in macular edema in DR. The technology of OCT is also applied to angiography (OCT angiograph: OCTA), which enables retinal vascular imaging without venous dye injection. Similar to OCTA, in terms of their low invasiveness, single blue color SLO image could be an alternative method in detecting non-perfused areas. Conventional optical photography has been gradually replaced to scanning laser ophthalmoscopy (SLO), which also make it possible to produce spectacular ultra-widefield (UWF) images. Since retinal vascular changes of DR are found in the whole retina up to periphery, it would be one of the best targets in UWF imaging. Additionally, evolvement of artificial intelligence (AI) has been applied to automated diagnosis of DR, and AI-based DR management is one of the major topics in this field. This review is trying to look back on the progress of imaging of DR comprehensively from the past to the present. MDPI 2022-07-11 /pmc/articles/PMC9319818/ /pubmed/35885588 http://dx.doi.org/10.3390/diagnostics12071684 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Horie, Shintaro
Ohno-Matsui, Kyoko
Progress of Imaging in Diabetic Retinopathy—From the Past to the Present
title Progress of Imaging in Diabetic Retinopathy—From the Past to the Present
title_full Progress of Imaging in Diabetic Retinopathy—From the Past to the Present
title_fullStr Progress of Imaging in Diabetic Retinopathy—From the Past to the Present
title_full_unstemmed Progress of Imaging in Diabetic Retinopathy—From the Past to the Present
title_short Progress of Imaging in Diabetic Retinopathy—From the Past to the Present
title_sort progress of imaging in diabetic retinopathy—from the past to the present
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319818/
https://www.ncbi.nlm.nih.gov/pubmed/35885588
http://dx.doi.org/10.3390/diagnostics12071684
work_keys_str_mv AT horieshintaro progressofimagingindiabeticretinopathyfromthepasttothepresent
AT ohnomatsuikyoko progressofimagingindiabeticretinopathyfromthepasttothepresent